



















The discovery that mutations in single genes can 
modulate aging was not only fascinating but it provided 
researchers with animal models with which to study 
aging in cohorts of different aging rates [1-2]. 
According to the GenAge database [3], at the time of 
writing, genetic manipulations in 68 genes have been 
shown to affect lifespan in mice. Among mouse genes 
in which mutations extend lifespan, a number are part of 
the growth hormone/insulin-like growth factor 1 
(GH/IGF1) axis. As such, it is widely acknowledged 
that decreased GH/IGF1signaling in mice can extend 
lifespan, while increased GH levels may accelerate 
aging [4-5]. Although the GH/IGF1axis is one of the 
major pathways regulating aging in mammals, its 
precise downstream mechanisms remain a subject of 
debate and scrutiny.   
 
In this year’s March issue of AGING, Borras et al. 
show that mice deficient in Rasgrf1, a guanine nucleo-
tide-releasing factor for Ras, exhibit a significant 
increase (~20%) in average and maximum lifespan. 
This increase in lifespan was independent of cancer 
mortality and was accompanied by a retardation in 
age-related functional and physiological decline [6]. 
Ras homologues have been associated with lifespan 
modulation in yeast [7], so it seems that Ras signaling 
is another example of an evolutionary conserved 
pathway modulating aging.  Rasgrf1 is unique among 
Ras family members, however, as it is only expressed 
in a few specific tissues, in particular in pancreatic 
β-cells and in some regions of the brain. Thus far, 
Rasgrf1 has been primarily associated with learning 
and memory [6, 8-9]. 
 
  


















Because of its expression in the brain, Rasgrf1 has been 
shown to regulate the synthesis and release of GH, and 
previous studies showed that Rasgrf1 deficient mice 
have lower levels of GH [9-10]. In line with these 
previous studies, and given that GH impacts on IGF1 
levels, Rasgrf1 deficient mice showed lower IGF1 
levels [6]. Decreased GH/IGF1 signaling results in 
stunted growth and reduced adult body size, which has 
been associated with life-extension in numerous models 
[11]. Borras et al. and other authors also observed that 
Rasgrf1deficient mice are smaller than controls [6, 9-
10]. Therefore, it is likely that decreased GH/IGF1 
signaling is the mechanism by which Rasgrf1 impacts 
on aging. Changes in GH/IGH1 have also been 
hypothesized to be related to the mechanisms of caloric 
restriction [4-5], which is in line with the observation by 
Borras et al., that Rasgrf1 deficient mice have metabolic 
profiles similar to mice under caloric restriction. 
 
Because Rasgrf1 mutants have altered GH/IGF1 
signaling, I had predicted that they would be long-lived 
[12]. Moreover, it was reported that bi-maternal mice 
are long-lived and, because Rasgrf1is an imprinted gene 
expressed from the paternal allele in neonates, it is 
possible that bi-maternal mice are long-lived due to 
Rasgrf1 effects [12-13]. Although conducted in 
different labs and strains, bi-maternal mice had a similar 
increase in average lifespan (28%), though a more 
modest increase in maximum lifespan (~5%). 
 
Rasgrf1 deficient mice are therefore another model to 
study the modulation of aging by the GH/IGF1 axis. 
Interestingly, mice expressing Rasgrf1from both alleles 
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could be seen as a complementary model to the Rasgrf1 
knock-outs. Consequently, since they are available with 
both increased GH (biallelic Rasgrf1 mice) and 
decreased GH levels (Rasgrf1 knock outs), the different 
Rasgrf1 mutant mice may be an excellent new model to 
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